<SEC-DOCUMENT>0001558370-24-005363-index.html : 20240419 <SEC-HEADER>0001558370-24-005363.hdr.sgml : 20240419 <ACCEPTANCE-DATETIME>20240419160540 ACCESSION NUMBER: 0001558370-24-005363 CONFORMED SUBMISSION TYPE: 424B4 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B4 SEC ACT: 1933 Act SEC FILE NUMBER: 333-276511 FILM NUMBER: 24857758 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>424B4 <SEQUENCE>1 <FILENAME>sngx-20231231x424b4.htm <DESCRIPTION>424B4 <TEXT> Document 1 - file: sngx-20231231x424b4.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>sngx-20231231x424b4001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: sngx-20231231x424b4001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>sngx-20231231x424b4008.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: sngx-20231231x424b4008.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>sngx-20231231x424b4009.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: sngx-20231231x424b4009.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>sngx-20231231x424b4024.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: sngx-20231231x424b4024.jpg
</DOCUMENT> </SEC-DOCUMENT>